Advanced search

Oral DHA supplementation in F508 homozygous cystic fibrosis patients.

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Van Biervliet, Stephanie, Saskia Vande Velde, T Delhaye, MARIEKE DEVOS, Armand Christophe, and Eddy Robberecht. 2008. “Oral DHA Supplementation in F508 Homozygous Cystic Fibrosis Patients.” In Acta Gastro-enterologica Belgica, 71:N03–N03.
APA
Van Biervliet, Stephanie, Vande Velde, S., Delhaye, T., DEVOS, M., Christophe, A., & Robberecht, E. (2008). Oral DHA supplementation in F508 homozygous cystic fibrosis patients. ACTA GASTRO-ENTEROLOGICA BELGICA (Vol. 71, pp. N03–N03). Presented at the 20th Belgian Week of Gastroenterology.
Vancouver
1.
Van Biervliet S, Vande Velde S, Delhaye T, DEVOS M, Christophe A, Robberecht E. Oral DHA supplementation in F508 homozygous cystic fibrosis patients. ACTA GASTRO-ENTEROLOGICA BELGICA. 2008. p. N03–N03.
MLA
Van Biervliet, Stephanie, Saskia Vande Velde, T Delhaye, et al. “Oral DHA Supplementation in F508 Homozygous Cystic Fibrosis Patients.” Acta Gastro-enterologica Belgica. Vol. 71. 2008. N03–N03. Print.
@inproceedings{2019509,
  author       = {Van Biervliet, Stephanie and Vande Velde, Saskia and Delhaye, T and DEVOS, MARIEKE and Christophe, Armand and Robberecht, Eddy},
  booktitle    = {ACTA GASTRO-ENTEROLOGICA BELGICA},
  issn         = {0001-5644},
  language     = {eng},
  location     = {Antwerp, Belgium},
  number       = {1},
  pages        = {N03--N03},
  title        = {Oral DHA supplementation in F508 homozygous cystic fibrosis patients.},
  volume       = {71},
  year         = {2008},
}